Non-Interventional Study to Evaluate Safety and Efficacy of NOVOCART 3D in Patients With Cartilage Defects

NCT02348697 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2019-12-03

No results posted yet for this study

Summary

Non-interventional study to evaluate safety and efficacy of NOVOCART 3D in adult and adolescent patients with full thickness cartilage defects after the treatment with NOVOCART 3D.

Conditions

  • Cartilage Diseases

Interventions

BIOLOGICAL

NOVOCART 3D

Autologous Chondrocyte Implantation

Sponsors & Collaborators

  • Aesculap AG

    collaborator INDUSTRY
  • Tetec AG

    lead INDUSTRY

Principal Investigators

  • Alexandra Kirner, PhD · TETEC AG Reutlingen

Eligibility

Min Age
14 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2019-10-30
Completion
2019-10-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02348697 on ClinicalTrials.gov